Oric Pharmaceuticals, Inc.·4

Jan 6, 4:42 PM ET

Piscitelli Dominic 4

4 · Oric Pharmaceuticals, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Piscitelli Dominic
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2026-01-02+206,500206,500 total
    Exercise: $8.17Exp: 2036-01-01Common Stock (206,500 underlying)
  • Award

    Restricted Stock Unit

    2026-01-02+34,50034,500 total
    Common Stock (34,500 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock.
  • [F3]1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028.

Documents

1 file
  • 4
    form4-01062026_090131.xmlPrimary